Searching map area
Rituximab
? TBD
Biopharmaceutical drug
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Subject of
15
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis
scientific article published on 04 May 2011
[Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy]
scientific article published on 01 October 2004
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
scientific article
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
scientific article published on February 20, 2013
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
scientific article published on 23 May 2008
IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
scientific article published on 20 February 2020
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
scientific article
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
scientific article published on 07 October 2019
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
scientific article published on 15 July 2010
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
scientific article published on 31 March 2016
5 more
Lists
0
Join to rate

Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis,...

Instance of
type of chemical entity
Subclass of
Chemical compound
Manufacturer
Pfizer
Wikidata